T
Timothy O. Wilson
Researcher at City of Hope National Medical Center
Publications - 79
Citations - 4982
Timothy O. Wilson is an academic researcher from City of Hope National Medical Center. The author has contributed to research in topics: Cystectomy & Prostatectomy. The author has an hindex of 33, co-authored 78 publications receiving 4555 citations. Previous affiliations of Timothy O. Wilson include University of Rochester & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
Andrea Mariani,Sean C. Dowdy,William A. Cliby,Bobbie S. Gostout,Monica Brown Jones,Timothy O. Wilson,Karl C. Podratz +6 more
TL;DR: The high rate of lymphatic metastasis above the IMA indicates the need for systematic pelvic and para-aortic lymphadenectomy up to the renal vessels and the latter should include consideration of excision of the gonadal veins.
Journal ArticleDOI
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
Giovanni Aletti,Sean C. Dowdy,Bobbie S. Gostout,Monica Brown Jones,C. Robert Stanhope,Timothy O. Wilson,Karl C. Podratz,William A. Cliby +7 more
TL;DR: Overall, residual disease was the only independent predictor of survival; the need to perform radical procedures to achieve optimal cytoreduction was not associated with a decrease in survival and minimizing residual disease through aggressive surgical resection was beneficial, especially in patients with carcinomatosis.
Journal ArticleDOI
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach.
D.B. Gough,John H. Donohue,A J Schutt,N Gonchoroff,John R. Goellner,Timothy O. Wilson,James M. Naessens,Peter C. O'Brien,J A van Heerden +8 more
TL;DR: Although PMP is an indolent disease, aggressive surgical debulking followed by intraperitoneal radioisotopes and/or chemotherapy should be considered because of the diffuse peritoneal involvement.
Journal ArticleDOI
Systematic Review and Cumulative Analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Cystectomy
Giacomo Novara,James W.F. Catto,Timothy O. Wilson,Magnus Annerstedt,Kevin Chan,Declan G. Murphy,Alexander Motttrie,James O. Peabody,Eila C. Skinner,Peter Wiklund,Khurshid A. Guru,Bertram Yuh +11 more
TL;DR: Cumulative analyses demonstrated that operative time was shorter with ORC, whereas RARC may provide some advantages in terms of blood loss and transfusion rates and, more limitedly, for postoperative complication rates over ORC and LRC.
Journal ArticleDOI
Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
Evanthia Galanis,Lynn C. Hartmann,William A. Cliby,Harry J. Long,Prema P. Peethambaram,Brigitte A. Barrette,Judith S. Kaur,Paul Haluska,Ileana Aderca,Paula J. Zollman,Jeff A. Sloan,Gary L. Keeney,Pamela J. Atherton,Karl C. Podratz,Sean C. Dowdy,C. Robert Stanhope,Timothy O. Wilson,Mark J. Federspiel,Kah-Whye Peng,Stephen J. Russell +19 more
TL;DR: The findings indicate that i.p. administration of MV-CEA is well tolerated and results in dose-dependent biological activity in a cohort of heavily pretreated recurrent ovarian cancer patients.